A case of fulminant type 1 diabetes after erythema multiforme.
PMID:
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R.
Lancet. 2016 Nov 5;388(10057):2254-2263. doi: 10.1016/S0140-6736(16)31535-5. Epub 2016 Sep 12.
PMID:27634581
Cutaneous Manifestations of Diabetes Mellitus: A Review.
Lima AL, Illing T, Schliemann S, Elsner P.
Am J Clin Dermatol. 2017 Aug;18(4):541-553. doi: 10.1007/s40257-017-0275-z.
PMID:28374407
Efficacy and safety of a rosehip seed oil extract in the prevention and treatment of skin lesions in the hands of patients with type 1 diabetes mellitus caused by finger prick blood glucose monitoring; a randomized, open-label, controlled clinical trial.
Aguirre-Romero AB, Galeano-Valle F, Conde-Montero E, Velázquez-Tarjuelo D, de-la-Cueva-Dobao P.
A case of fulminant type 1 diabetes after erythema multiforme.
Ma Z, Zhang W.
Diabetes Res Clin Pract. 2016 Oct;120:182-3. doi: 10.1016/j.diabres.2016.08.003. Epub 2016 Aug 19.
PMID:27580389
"Out of the box" solution for skin problems due to glucose-monitoring technology in youth with type 1 diabetes: real-life experience with fluticasone spray.
Paret M, Barash G, Rachmiel M.
Acta Diabetol. 2020 Apr;57(4):419-424. doi: 10.1007/s00592-019-01446-y. Epub 2019 Nov 8.
PMID:31705297
Cutaneous adverse events in a randomized controlled trial of flash glucose monitoring among youth with type 1 diabetes mellitus.